Contributing to high genetic testing accuracy using a reference material containing a known number of DNA molecules ∼
Contributing to high genetic testing accuracy using a reference material containing a known number of DNA molecules ∼
Kyocera Corporation (NYSE:KYO)(TOKYO:6971) today announced that its innovative Aquala technology received Japan’s “Prize of the Minister of Economy, Trade and Industry” during the 2018 National Invention Awards held in Tokyo June 12 by the Japan Institute of Invention and Innovation (JIII).
SABIC, a global leader in the chemical industry, announced here at NPE 2018, booth S19001, the third expansion of its additive manufacturing materials offering within 12 months. Specifically, SABIC is launching three new filaments for fused deposition modeling: ULTEM™ AM1010F filament for general high-temperature applications, including tooling; and ULTEM™ AMHU1010F and LEXAN™ AMHC620F filaments for healthcare applications. These advanced new materials, which can be used for end-use parts as well as prototypes, are key to SABIC’s strategy of extending the scope of additive manufacturing. The company is also applying its broad expertise in materials, processing and design optimization – as well as deep knowledge and experience in healthcare – to enhance additive manufacturing technologies.
Printed replacement human body parts might seem like science fiction, but this technology is rapidly becoming a reality with the potential to greatly contribute to regenerative medicine. Before any real applications, "bioprinting" still faces many technical challenges. Processing the bio-ink and making it stick to itself and hold the desired printed gel structure have been proving particularly difficult especially in inkjet printing. Few methods currently exist for gluing bio-ink droplets together and these do not work for every kind of cell, motivating new alternative approaches.
3D printing technology has been applied across a wide range of applications in healthcare, providing customised anatomical models and surgical tools that facilitate training and planning of complex surgeries, as well as increasingly sophisticated customised implants and prosthetics that offer better fit and functionality for patients.
The Department of Food Science at the University of Copenhagen is taking part in a new research collaboration that aims to use 3D printing technology to tailor meals for individual hospital patients without the need for additional resources in the hospital kitchen.
3dbiosurfaces and STRATEC Consumables GmbH, a wholly owned subsidiary of STRATEC, announced today the release of the first commercially available microarray substrate based on 3dbiosurfaces patented and patent-pending technologies.
3D bioprinting, or the 3D printing of implantable, living tissue, can certainly be considered the Holy Grail of 3D printing. Various ongoing research projects throughout the
A chemical compound developed by University of British Columbia researchers makes it possible to create biological tissue with a light projector you can buy at Walmart. The compound, a new type of biological ink used in the 3D printing of tissue, eliminates the need to use UV light systems in favour of safer, more conventional light.
BioBots is a company launched by Daniel Cabrera, a recent graduate of University of Pennsylvania’s Engineering School, as well as Ricardo Solorzano and Sohaib Hashmi, who are staff research specialists in the Perelman School of Medicine (UPenn). The three got together to create a 3D bioprinter capable of printing in multiple body tissues. While this certainly isn’t the first ever bioprinter created, Cabrera tells us that it is not the same as others on the market today.
Bioprinting is changing how we do biology.
Yet another huge milestone in bioprinting research for our most versatile bioprinting development system has been reached with the study of the scaffold for a tympanic membrane. This is an exciting step toward the bioprinting of complex implantable cartilage structures, a process that is already close to practical applications.